论文部分内容阅读
心房按需(AAI)起搏应用于临床已有20余年的历史。80年代以来,由于心房导管电极的改进、高灵敏度程控起搏器的出现和选择适应症的合理,AAI作为一种初级的生理性起搏,在病窦综合征(SSS)患者中的应用,已日渐增多,尤以欧洲的瑞典、民主德国、意大利等国为然。1988年,民主德国学者Witte在北京曾就AAI起搏的研究和临床应用作了介绍,从而引起了国内心内科医师对于AAI起搏的重视。目前,在西安、北京、上海等地已先后将AAI起搏成功地应用于临床。我们于1990年初采用秦明医学仪器有限公司的Pinnacle8619型起搏器和J型
Atrial demand (AAI) pacing has been used clinically for more than 20 years. Since the 1980s, due to the improvement of atrial catheter electrode, the emergence of high-sensitivity programmable pacemaker and the reasonable choice of indications, AAI as a primary physiological pacing in patients with sick sinus syndrome (SSS) Has been increasing, especially in Europe, Sweden, Germany, Germany and other countries. In 1988, Witte, a German democratic German scholar, introduced the research and clinical application of AAI pacing in Beijing, which attracted the attention of domestic cardiologists in AAI pacing. At present, in Xi’an, Beijing, Shanghai and other places have been successfully applied to the clinical AAI pacing. In early 1990, we used the Pinnacle 8619 pacemaker from Qin Ming Medical Instruments Co., Ltd. and J type